サンバイオの株価時系列
| 日付 | 始値 | 高値 | 安値 | 終値 | 前日比 | 騰落率 | 出来高 |
|---|---|---|---|---|---|---|---|
| 2022/06/10 | 1,114 | 1,118 | 1,093 | 1,096 | -24 | -2.1% | 328,600 |
| 2022/06/09 | 1,115 | 1,126 | 1,102 | 1,120 | +5 | +0.4% | 305,700 |
| 2022/06/08 | 1,108 | 1,119 | 1,085 | 1,115 | +28 | +2.6% | 362,400 |
| 2022/06/07 | 1,111 | 1,113 | 1,086 | 1,087 | -24 | -2.2% | 204,200 |
| 2022/06/06 | 1,082 | 1,112 | 1,078 | 1,111 | +27 | +2.5% | 297,100 |
| 2022/06/03 | 1,095 | 1,098 | 1,070 | 1,084 | +6 | +0.6% | 233,000 |
| 2022/06/02 | 1,087 | 1,087 | 1,058 | 1,078 | -9 | -0.8% | 227,200 |
| 2022/06/01 | 1,106 | 1,116 | 1,082 | 1,087 | -19 | -1.7% | 311,600 |
| 2022/05/31 | 1,103 | 1,125 | 1,088 | 1,106 | -4 | -0.4% | 373,300 |
| 2022/05/30 | 1,086 | 1,111 | 1,069 | 1,110 | +39 | +3.6% | 399,900 |
| 2022/05/27 | 1,051 | 1,076 | 1,041 | 1,071 | +24 | +2.3% | 262,800 |
| 2022/05/26 | 1,050 | 1,059 | 1,036 | 1,047 | +3 | +0.3% | 284,500 |
| 2022/05/25 | 1,106 | 1,106 | 1,043 | 1,044 | -60 | -5.4% | 567,700 |
| 2022/05/24 | 1,126 | 1,132 | 1,096 | 1,104 | -41 | -3.6% | 262,100 |
| 2022/05/23 | 1,150 | 1,152 | 1,120 | 1,145 | ±0 | ±0% | 329,600 |
| 2022/05/20 | 1,125 | 1,147 | 1,108 | 1,145 | +31 | +2.8% | 275,000 |
| 2022/05/19 | 1,090 | 1,123 | 1,087 | 1,114 | -5 | -0.4% | 207,900 |
| 2022/05/18 | 1,103 | 1,120 | 1,089 | 1,119 | +23 | +2.1% | 246,200 |
| 2022/05/17 | 1,084 | 1,098 | 1,073 | 1,096 | +12 | +1.1% | 211,100 |
| 2022/05/16 | 1,075 | 1,088 | 1,067 | 1,084 | +13 | +1.2% | 343,400 |
| 2022/05/13 | 1,066 | 1,080 | 1,043 | 1,071 | +9 | +0.8% | 347,900 |
| 2022/05/12 | 1,102 | 1,102 | 1,062 | 1,062 | -54 | -4.8% | 406,000 |
| 2022/05/11 | 1,113 | 1,125 | 1,077 | 1,116 | +3 | +0.3% | 443,400 |
| 2022/05/10 | 1,127 | 1,135 | 1,106 | 1,113 | -17 | -1.5% | 294,800 |
| 2022/05/09 | 1,135 | 1,168 | 1,123 | 1,130 | -20 | -1.7% | 429,600 |
| 2022/05/06 | 1,120 | 1,150 | 1,106 | 1,150 | +38 | +3.4% | 359,000 |
| 2022/05/02 | 1,112 | 1,139 | 1,101 | 1,112 | ±0 | ±0% | 504,300 |
| 2022/04/28 | 1,105 | 1,131 | 1,094 | 1,112 | +7 | +0.6% | 414,000 |
| 2022/04/27 | 1,101 | 1,114 | 1,088 | 1,105 | -18 | -1.6% | 269,000 |
| 2022/04/26 | 1,126 | 1,130 | 1,090 | 1,123 | +6 | +0.5% | 279,900 |
| 2022/04/25 | 1,100 | 1,132 | 1,100 | 1,117 | -12 | -1.1% | 256,900 |
| 2022/04/22 | 1,142 | 1,144 | 1,113 | 1,129 | -30 | -2.6% | 291,800 |
| 2022/04/21 | 1,137 | 1,163 | 1,133 | 1,159 | +18 | +1.6% | 301,600 |
| 2022/04/20 | 1,140 | 1,147 | 1,119 | 1,141 | +4 | +0.4% | 261,700 |
| 2022/04/19 | 1,112 | 1,139 | 1,105 | 1,137 | +25 | +2.2% | 315,600 |
| 2022/04/18 | 1,156 | 1,157 | 1,105 | 1,112 | -49 | -4.2% | 560,500 |
| 2022/04/15 | 1,170 | 1,184 | 1,158 | 1,161 | -15 | -1.3% | 351,600 |
| 2022/04/14 | 1,171 | 1,197 | 1,156 | 1,176 | +8 | +0.7% | 541,400 |
| 2022/04/13 | 1,170 | 1,181 | 1,145 | 1,168 | +4 | +0.3% | 380,600 |
| 2022/04/12 | 1,155 | 1,173 | 1,141 | 1,164 | -10 | -0.9% | 312,900 |
| 2022/04/11 | 1,153 | 1,175 | 1,140 | 1,174 | +4 | +0.3% | 406,400 |
| 2022/04/08 | 1,150 | 1,178 | 1,138 | 1,170 | +18 | +1.6% | 470,400 |
| 2022/04/07 | 1,190 | 1,193 | 1,141 | 1,152 | -50 | -4.2% | 973,500 |
| 2022/04/06 | 1,290 | 1,303 | 1,180 | 1,202 | -4 | -0.3% | 3,335,000 |
| 2022/04/05 | 1,195 | 1,215 | 1,180 | 1,206 | +15 | +1.3% | 576,400 |
| 2022/04/04 | 1,200 | 1,210 | 1,181 | 1,191 | +7 | +0.6% | 475,500 |
| 2022/04/01 | 1,193 | 1,204 | 1,177 | 1,184 | -21 | -1.7% | 637,800 |
| 2022/03/31 | 1,194 | 1,212 | 1,175 | 1,205 | +6 | +0.5% | 612,900 |
| 2022/03/30 | 1,224 | 1,224 | 1,182 | 1,199 | -6 | -0.5% | 616,700 |
| 2022/03/29 | 1,225 | 1,228 | 1,194 | 1,205 | -17 | -1.4% | 749,800 |
751～
800
件表示中 / 2501件
類似銘柄と比較する
現在ご覧いただいている「サンバイオ」と類似性の高い銘柄をピックアップ。投資家が注目しているデータで比較できるようになっています。銘柄選びの参考情報としてご活用ください。
| 銘柄名 | 最低購入代金 | 売上高 成長率 |
経常 増益率 |
配当 利回り |
PER | PBR | 直近のチャート | 特色 |
|---|---|---|---|---|---|---|---|---|
| サンバイオ | 222,200円 | - | - | 0.00% | - | 102.91倍 |
|
脳疾患向け再生細胞薬の開発・製造・販売目指すバイオベンチャー。米国で創業し日本に逆上陸 |
| 科研薬 | 378,200円 | -6.4% | -71.8% | 5.02% | 42.24倍 | 0.94倍 |
|
旧理研グループの名門。導入の関節機能改善剤、自社創製の爪白癬症薬の２本柱。後発品も展開 |
| ジーエヌアイ | 311,500円 | +21.7% | +999.9% | 0.00% | 13.06倍 | 4.32倍 |
|
中国の特発性肺線維症で高シェア、肺線維症後続薬進出。米国で人工骨も。米中に研究開発機能 |
| 東和薬品 | 293,400円 | +7.9% | -3.3% | 2.73% | 8.16倍 | 0.84倍 |
|
後発医薬品メーカーで国内２強の一角。循環器系に強い。直販軸に発展も卸との取引を拡大中 |
| ゼリア新薬 | 203,800円 | +3.1% | -6.5% | 2.36% | 9.45倍 | 1.01倍 |
|
製薬中堅。医療用は消化器系中心。滋養強壮剤「ヘパリーゼ」も柱。スイス企業買収で海外展開 |
市場注目の銘柄
チャート関連のコラム
